MONDAY, Aug. 5, 2019 (American Heart Association News) -- Many men with prostate cancer rely on common testosterone-blocking drugs as a part of their treatment. But those so-called antiandrogens also might put them at risk for a deadly heart condition, according to new research.
In a study published Monday in the American Heart Association journal Circulation, researchers looked at how several testosterone-blocking drugs affect the heart's QT interval – the time it takes the heart cells to recharge in between beats.
WEDNESDAY, July 10, 2019 -- It's long been known that sugary drinks help people pack on unwanted pounds. But new research suggests that sweetened sodas, sports drinks and even 100% fruit juice might raise your risk for some cancers.
The study couldn't prove cause and effect, but it found that drinking as little as 3 to 4 ounces of sugary drinks each day was tied to an 18% rise in overall risk for cancer.
MONDAY, July 1, 2019 -- Patients who receive radioactive iodine treatment for an overactive thyroid have an increased long-term risk of cancer death, new research finds.
The study couldn't prove cause-and-effect, but "we identified a clear dose-response relationship between this widely used treatment and long-term risk of death from solid cancer, including breast cancer, in the largest cohort study to date of patients treated for hyperthyroidism," said lead author Cari Kitahara. She's with the Division of Cancer Epidemiology and Genetics at the U.S. National Cancer Institute (NCI).